Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Debt Ratio: 2020-2025

Historic Debt Ratio for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to 0.34.

  • Maravai Lifesciences Holdings' Debt Ratio fell 15.52% to 0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.34, marking a year-over-year decrease of 15.52%. This contributed to the annual value of 0.29 for FY2024, which is 16.71% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Debt Ratio stood at 0.34, which was up 5.25% from 0.33 recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Debt Ratio registered a high of 0.41 during Q3 2024, and its lowest value of 0.23 during Q4 2022.
  • Its 3-year average for Debt Ratio is 0.32, with a median of 0.33 in 2025.
  • In the last 5 years, Maravai Lifesciences Holdings' Debt Ratio slumped by 40.76% in 2022 and then surged by 76.30% in 2024.
  • Maravai Lifesciences Holdings' Debt Ratio (Quarterly) stood at 0.39 in 2021, then plummeted by 40.76% to 0.23 in 2022, then soared by 52.48% to 0.35 in 2023, then declined by 16.71% to 0.29 in 2024, then decreased by 15.52% to 0.34 in 2025.
  • Its Debt Ratio was 0.34 in Q3 2025, compared to 0.33 in Q2 2025 and 0.31 in Q1 2025.